Maitreya Medicare Ltd

Maitreya Medicare Other Announcement

Maitreya Medicare Limited confirms there is no deviation in the utilization of IPO proceeds for the half year ended September 30, 2026.

Maitreya Medicare H1 FY27 Results: Net Loss of ₹0.9 Cr

Maitreya Medicare Ltd reported revenue from operations of ₹23.7 Cr (+0.0% YoY) and a net loss of ₹0.9 Cr for H1 FY27.

Key figure

Net loss ₹0.9 Cr

Maitreya Medicare Other Announcement

Maitreya Medicare Limited has filed a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.

Maitreya Medicare Management Change

Maitreya Medicare Limited has announced the resignation of Ms. Kashish Surana from the position of Company Secretary and Compliance Officer, effective October 01, 2026.

Maitreya Medicare Annual General Meeting

Maitreya Medicare Limited held its 07th Annual General Meeting on September 21, 2026. The meeting discussed the adoption of financial statements and a director's re-appointment.

Maitreya Medicare Annual General Meeting

Maitreya Medicare Limited approved the scheduling of its 7th Annual General Meeting for September 21, 2026. The board also approved the Director's report and appointed a scrutinizer.

Maitreya Medicare Fund Raise of ₹14.89 Cr

Maitreya Medicare Limited reported zero deviation in the utilization of its ₹14.89 Crore IPO proceeds. Funds were deployed toward subsidiary investments, debt redemption, and working capital.

Value

₹14.89 Cr

Maitreya Medicare Management Change

Maitreya Medicare Limited re-appointed JDM and Associates LLP as Secretarial Auditors for FY 2026-27. This move ensures continued regulatory compliance and statutory oversight.

Execution

Financial Year 2026-27

Maitreya Medicare Board Meeting Outcome

Maitreya Medicare appointed R P V & Company as Internal Auditor and re-appointed JDM and Associates as Secretarial Auditor. Both appointments carry 12-month terms.

Execution

12 months

Maitreya Medicare H2 FY26 Results: Net Loss of ₹2.4 Cr

Maitreya Medicare Ltd reported revenue from operations of ₹21.2 Cr (-4.9% YoY) and a net loss of ₹2.4 Cr for H2 FY26.

Key figure

Net loss ₹2.4 Cr

Maitreya Medicare Financial Results

Maitreya Medicare Limited approved its audited standalone and consolidated financial results for the year ended March 31, 2026. The Board also approved auditor re-appointments and preference share redemptions.

Maitreya Medicare Management Change

Dr. Pranav Rohitbhai Thaker resigned as Whole-time Director and Founder effective May 25, 2026. He cited personal and professional commitments for his departure.

Maitreya Medicare Board Meeting Date

Maitreya Medicare scheduled a board meeting for May 29, 2026, to approve audited annual financial results. Trading window remains closed until June 1, 2026.

Maitreya Medicare Annual General Meeting

Maitreya Medicare Limited announced the results of its postal ballot today. Shareholders unanimously approved the 'Maitreya Medicare Limited – Employee Stock Option Scheme 2026' with 100.00% of votes in favour. The voting process, scrutinised by JDM and Associates LLP, concluded with 17,68,240 valid electronic votes cast for the resolution.

Maitreya Medicare Other Announcement

Maitreya Medicare Limited submitted an exemption notice regarding the non-applicability of the Annual Secretarial Compliance Report for the financial year ended March 31, 2026. As an SME-listed entity on the NSE Emerge platform, the company is exempt from certain SEBI LODR compliance requirements under Regulation 15(2). This is a routine regulatory update for investors.

Maitreya Medicare Other Announcement

Maitreya Medicare Limited submitted a non-applicability certificate regarding Corporate Governance and Secretarial Compliance reports. As an NSE SME listed entity below specified thresholds, it is exempt from Regulation 27(2) and 24A for the period ended March 31, 2026. This is a routine regulatory compliance filing.

Maitreya Medicare Other Announcement

Maitreya Medicare Limited submitted its Structured Digital Database (SDD) Compliance Certificate for the financial year ended March 31, 2026. The certificate confirms that the company maintains a non-tamperable internal database to capture unpublished price-sensitive information (UPSI) in compliance with SEBI Insider Trading Regulations.

Maitreya Medicare Other Announcement

Maitreya Medicare Limited submitted its quarterly and annual compliance certificate under SEBI (Depositories and Participants) Regulations for the period ended March 31, 2026. The certificate confirms that security certificates received for dematerialisation were processed and substituted in the register of members within prescribed timelines.